Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Massive upside here.

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
J.D. Penny Member Profile
 
Followed By 68
Posts 2,721
Boards Moderated 0
Alias Born 03/01/13
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/9/2020 7:10:18 AM
Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors GlobeNewswire Inc. - 12/12/2019 11:35:07 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/12/2019 7:09:34 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/5/2019 8:08:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/4/2019 7:15:18 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/19/2019 8:46:02 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/9/2019 6:16:44 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/6/2019 2:12:28 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/13/2019 6:01:04 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 8/5/2019 7:33:04 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/5/2019 7:02:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/2/2019 7:00:57 AM
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting PR Newswire (US) - 6/3/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/30/2019 10:19:20 AM
Compugen to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/22/2019 7:00:00 AM
Compugen Reports First Quarter 2019 Results PR Newswire (US) - 5/20/2019 7:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/20/2019 7:01:27 AM
Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid ... PR Newswire (US) - 5/20/2019 7:00:00 AM
Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET PR Newswire (US) - 5/6/2019 7:00:00 AM
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting PR Newswire (US) - 4/3/2019 7:00:00 AM
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules PR Newswire (US) - 3/26/2019 8:40:00 AM
Compugen Announces Purchase of Company Shares by its Board of Directors and Members of Management PR Newswire (US) - 3/26/2019 7:00:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 3/21/2019 6:43:17 AM
Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Product Candidate PR Newswire (US) - 3/12/2019 7:46:00 AM
Compugen to Present at the Cowen and Company 39th Annual Health Care Conference PR Newswire (US) - 3/5/2019 7:00:00 AM
J.D. Penny   Friday, 11/29/19 10:09:04 PM
Re: None
Post # of 176 
Massive upside here.

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist